August 30, 2012
SHANTOU, ChinaOn Aug. 20, Sirio Pharma Co. passed the on-site audit of Australia's Therapeutic Goods Administration (TGA)-good manufacturing practice (GMP) certification. The Chinese contract manufacturer provides softgel, tablet and gummy dietary supplements.
The Australian government controls and issues TGA-GMP certification for medicinal products containing herbs, vitamins, minerals and nutritional supplements, in addition to homeopathic medicines and aromatherapy products. The TGA-GMP certification is recognized and accepted by more than 20 Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme members.
You May Also Like
Sep 28, 2023
Innovation in stress and sleep management: Holixer™– white paperSep 22, 2023
Probi study finds subjects’ brains worked better under stress with probioticSep 29, 2023
Cognitive health growth comes out on top: A range of solutions for diverse needs continue to emerge and win – product development guideSep 25, 2023
LifeVantage proxy fight heats up as revenues coolSep 28, 2023